-
Electronic (PDF)
-
1 - 5 Users
-
Enterprisewide
Global Pharmaceuticals Market 2011-2015
Infiniti Research Limited, July 2012, Pages: 75
TechNavio's analysts forecast the Global Pharmaceuticals market to grow at a CAGR of 7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the rising demand of drugs in the emerging markets. The Global Pharmaceuticals market has also been witnessing a paradigm shift towards biologic drugs. However, the patent expiration of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Pharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pharmaceuticals market landscape by Chemical Properties, by Commercialization, by Legal Consideration, and by Therapeutic Area, and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and Roche Holding Ltd.
Other vendors mentioned in the report: Abbott Laboratories Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca plc., Baxter International Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Cephalon Inc., Eisai Co. Ltd., Eli Lilly and Co., Forest Laboratories Inc., GlaxoSmithKline plc., Hospira Inc., Johnson & Johnson Ltd., Mylan Inc., Novo Nordisk A/S, Otsuka Holdings Co. Ltd., Schering-Plough Corp., Shire plc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical, and UCB S.A.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio today launched its report Global Pharmaceuticals Market 2011-2015 based on an in-depth study covering the Americas and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; “Biologic drugs provide sufficient growth opportunities for vendors in this market as there is increasing demand for biopharmaceuticals for the treatment of various diseases. As a result, vendors in the market are investing heavily in R&D to develop novel biologic components. Additionally, it is estimated that by 2016, biologic drugs will account for a massive share of the sales of pharmaceutical products.”
According to the report, the increasing prevalence of diseases leads to the demand for various drugs used to treat them, resulting in the growth of the Global Pharmaceuticals market.
Further, the report also discusses that the patent expiry of top-selling drugs is a major challenge in this market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size
04.1 Global Pharmaceuticals Market Segmentation
04.2 Market Segmentation by Chemical Property
Global Biopharmaceuticals Market
Global Chemically Synthesized Drugs Market
04.3 Market Segmentation by Commercialization
Global Generic Drugs Market
Global Branded Drugs Market
04.4 Market Segmentation by Legal Consideration
Global Prescription Drugs Market
Global Over-the-counter Drugs Market
04.5 Market Segmentation by Therapeutic Area
Global Cancer Drugs Market
Global Musculoskeletal Drugs Market
Global Gastrointestinal Drugs Market
Global Ophthalmology Drugs Market
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
USA
Japan
Germany
Economic Indicators of Key Leading Countries
07. Rate of Incidence and Prevalence
Cardiovascular Diseases
Neurological Disorders
Cancer
Diabetes
Musculoskeletal Diseases
08. Vendor Landscape
08.1 Global Pharmaceuticals Market
08.2 Global Biopharmaceuticals Market
08.3 Global Generic Drugs Market
08.4 Global Branded Drugs Market
Product Portfolio Matrix
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Pfizer Inc.
Business Overview
SWOT Analysis
15.2 Novartis AG
Business Overview
SWOT Analysis
15.3 Merck and Co. Inc.
Business Overview
SWOT Analysis
15.4 Sanofi S.A.
Business Overview
SWOT Analysis
15.5 Roche Holding Ltd.
Business Overview
SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Pharmaceuticals Market 2011-2015 (US$ billion)
Exhibit 2: Global Pharmaceuticals Market Segmentation
Exhibit 3: Market Segmentation by Chemical Property
Exhibit 4: Global Pharmaceuticals Market Segmentation by Chemical Property 2011
Exhibit 5: Global Biopharmaceuticals Market 2011-2015 (US$ billion)
Exhibit 6: Global Chemically Synthesized Drugs Market 2011-2015 (US$ billion)
Exhibit 7: Market Segmentation by Commercialization
Exhibit 8: Global Pharmaceuticals Market Segmentation by Commercialization 2011
Exhibit 9: Global Generic Drugs Market 2011-2015 (US$ billion)
Exhibit 10: Global Branded Drugs Market 2011-2015 (US$ billion)
Exhibit 11: Market Segmentation by Legal Consideration
Exhibit 12: Global Pharmaceuticals Market Segmentation by Legal Consideration 2011
Exhibit 13: Global Prescription Drugs Market 2011-2015 (US$ billion)
Exhibit 14: Global Over-the-counter Drugs Market 2011-2015 (US$ billion)
Exhibit 15: Market Segmentation by Therapeutic Area 2011
Exhibit 16: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011
Exhibit 17: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011-2015 (percentage)
Exhibit 18: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011-2015 (US$ billion)
Exhibit 19: Global Cancer Drugs Market 2011-2015 (US$ billion)
Exhibit 20: Global Musculoskeletal Drugs Market 2011-2015 (US$ billion)
Exhibit 21: Global Gastrointestinal Drugs Market 2011-2015 (US$ billion)
Exhibit 22: Global Ophthalmology Drugs Market 2011-2015 (US$ billion)
Exhibit 23: Global Pharmaceuticals Market by Geographical Segmentation 2011
Exhibit 24: Global Pharmaceuticals Market by Vendor Segmentation 2011
Exhibit 25: Global Biopharmaceuticals Market by Vendor Segmentation 2011
Exhibit 26: Global Generic Drugs Market by Vendor Segmentation 2011
Exhibit 27: Global Branded Drugs Market by Vendor Segmentation 2011
Merck and Co, Novartis AG, Pfizer, Sanofi S.A., Roche Holding
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
